Our team develop new antitumoral therapies associated to radio- and/or chemo-therapy to fight cancer resistance to treatment while limiting adverse effects. New small molecules named DBAit that inhibit major DNA Repair pathways During these last years we have: Analyzed the mechanism of action of DBait (short double-stranded DNA mimicking double-strand break). Developed derived Dbait molecules […]
Read more
